Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   HEPATITIS MONTHLY   MAY 2011 , Volume 11 , Number 5 (34); Page(s) 382 To 383.
 
Paper: 

LIVER FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASES: ARE LABORATORY TESTS USEFUL TO DIAGNOSIS? (LETTER TO EDITOR)

 
 
Author(s):  LEONARDI SALVATORE*, VITALITI GIOVANNA
 
* DEPARTMENT OF PEDIATRICS, UNIVERSITY OF CATANIA, VIA SANTA SOFIA 78, AOU POLICLINICO-OVE, CATANIA, ITALY
 
Abstract: 

The article published in Hepatitis Monthy on noninvasive assessment of liver fibrosis with the aspartate transaminasis to platelet ratio index (APRI) in patients with chronic liver disease by Yilmazet al. (1), is interesting and very useful to permit a diagnosis and staging of fibrosis, although this index does not seem to have a high sensitivity and specificity. In recent years, efforts have been made to develop non-invasive predictive models that may correlate with stage of fibrosis. One of the first non-invasive predictive models for patients with chronic hepatitis C (CHC) was the Fibrotest, which includes a2-macroglobulin, haptoglobin, g -glutamil-transferase (GGT), apolipoprotein A1 and total bilirubin. However, considerable expenses and use of uncommon parameters reduce their clinical applicability. A few years later, the Forns’ score (age, GGT, cholesterol, platelets and prothrombin) and the APRI index (AST and platelets) overcame these draw-backs by use of only standard laboratory tests in the development of their predictive models.

 
Keyword(s): LIVER FIBROSIS, DIAGNOSIS
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 98
 
Latest on Blog
Enter SID Blog